organophosphonates has been researched along with Invasiveness, Neoplasm in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aiba, S; Fujimura, T; Furudate, S; Kambayashi, Y | 1 |
| Baker, DL; Bolen, AL; Emmons-Thompson, K; Fells, J; Fujiwara, Y; Gupte, R; Lee, SC; Liu, J; Miller, DD; Mills, GB; Panupinthu, N; Parrill, AL; Patil, R; Pham, TC; Siddam, A; Tigyi, G; Wang, Y; Yates, CR | 1 |
| Balazs, L; Fells, J; Fujiwara, Y; Gotoh, M; Gupte, R; Kennel, S; Lee, S; Liu, J; Miller, DD; Murakami-Murofushi, K; Patil, R; Tigyi, GJ; Uchiyama, A; Wall, J; Yue, J | 1 |
| Breuer, E; Chen, W; Hadar, R; Katz, Y; Lu, S; Reich, R; Röschenthaler, GV; Salomon, CJ | 1 |
| Breuer, E; Hadar, R; Katz, Y; Reich, R | 1 |
| Appella, DH; Avram, MJ; Ghosh, S; Huang, S; Kawamura, A; Luong, L; Norton, JT; Sim, E; Stack, MS; Witschi, MA | 1 |
| Bhusare, SR; Breuer, E; Frant, J; Hadar, R; Hoffman, A; Katz, Y; Qadri, B; Reich, R | 1 |
| De Boeck, K; De Clercq, E; Feenstra, L; Snoeck, R; Van Valckenborgh, I; Wellens, W | 1 |
1 review(s) available for organophosphonates and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis.
Topics: Animals; Antineoplastic Agents; Humans; Lysophospholipids; Molecular Targeted Therapy; Neoplasm Invasiveness; Neoplasms; Organophosphonates; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Receptors, Lysophosphatidic Acid; Signal Transduction; Xenograft Model Antitumor Assays | 2012 |
7 other study(ies) available for organophosphonates and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Potential use of bisphosphonates in invasive extramammary Paget's disease: an immunohistochemical Investigation.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Female; Genital Neoplasms, Female; Genital Neoplasms, Male; Humans; Immunohistochemistry; Immunologic Factors; Immunomodulation; Lymphatic Metastasis; Macrophages; Male; Neoplasm Invasiveness; Organophosphonates; Paget Disease, Extramammary; Skin; T-Lymphocytes, Cytotoxic | 2013 |
Benzyl and naphthalene methylphosphonic acid inhibitors of autotaxin with anti-invasive and anti-metastatic activity.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Disease Models, Animal; Enzyme Inhibitors; Humans; Liver Neoplasms; Melanoma, Experimental; Mice; Multienzyme Complexes; Naphthalenes; Neoplasm Invasiveness; Neoplasm Metastasis; Organophosphonates; Organophosphorus Compounds; Phosphodiesterase I; Phosphoric Diester Hydrolases; Pyrophosphatases | 2011 |
Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Basement Membrane; Capillaries; Cell Line, Tumor; Drug Screening Assays, Antitumor; Hydrogen-Ion Concentration; In Vitro Techniques; Matrix Metalloproteinase Inhibitors; Mice; Neoplasm Invasiveness; Organophosphonates; Protein Binding; Solubility; Structure-Activity Relationship; Zinc | 2004 |
Carbamoylphosphonate matrix metalloproteinase inhibitors 3: in vivo evaluation of cyclopentylcarbamoylphosphonic acid in experimental metastasis and angiogenesis.
Topics: Animals; Chemotaxis; Disease Models, Animal; Female; Humans; Lung Neoplasms; Matrix Metalloproteinase Inhibitors; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Organophosphonates | 2005 |
Synthesis and anticancer activities of 6-amino amonafide derivatives.
Topics: Acetylation; Adenine; Animals; Antineoplastic Agents; Arylamine N-Acetyltransferase; Cell Line, Tumor; Cell Nucleolus; Cell Proliferation; DNA; DNA Damage; Humans; Imides; Intercalating Agents; Isoquinolines; Magnetic Resonance Spectroscopy; Naphthalimides; Neoplasm Invasiveness; Organophosphonates; Structure-Activity Relationship; Subcellular Fractions; Topoisomerase I Inhibitors | 2008 |
Carbamoylphosphonate matrix metalloproteinase inhibitors 6: cis-2-aminocyclohexylcarbamoylphosphonic acid, a novel orally active antimetastatic matrix metalloproteinase-2 selective inhibitor--synthesis and pharmacodynamic and pharmacokinetic analysis.
Topics: Animals; Antineoplastic Agents; Biological Availability; Cell Line, Tumor; Cobamides; Cyclohexanes; Female; Humans; In Vitro Techniques; Intestinal Absorption; Male; Matrix Metalloproteinase Inhibitors; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, SCID; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Organophosphonates; Prostatic Neoplasms; Rats; Structure-Activity Relationship; Tissue Distribution; Toxicity Tests, Acute | 2008 |
Systemic cidofovir in papillomatosis.
Topics: Antiviral Agents; Child; Cidofovir; Cytosine; Female; Humans; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Organophosphonates; Organophosphorus Compounds; Papilloma; Respiratory Tract Neoplasms; Tomography, X-Ray Computed | 2001 |